It was reported through patient outcome that the patient passed away on (b)(6) 2021 from right ventricular failure.Although death was not considered to be device related patient had medical history of peripartum cardiomyopathy, acute renal failure, ventricular tachycardia, acute iliofemoral clot and popliteal clot required fasciotomy, respiratory failure, leukocytosis, history of pulmonary embolisms, copd, and diabetes.
|
Manufacturer's investigation conclusion: a correlation between the device and the reported peripartum cardiomyopathy, acute renal failure, ventricular tachycardia, acute iliofemoral clot and popliteal clot requiring fasciotomy, respiratory failure, leukocytosis, history of pulmonary embolism, chronic obstructive pulmonary disease, diabetes, and patient outcome could not be conclusively determined during this evaluation.A specific cause for these events could also not be determined.Heartmate 3 left ventricular assist system (lvas), serial number (b)(6), was not explanted for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.Section 1 "introduction" of the heartmate (hm) 3 left ventricular assist system (lvas) instructions for use (ifu) lists the adverse events that may be associated with the use of the heartmate 3 left ventricular assist system, including right heart failure, venous thromboembolism, arterial non-central nervous system thromboembolism, renal dysfunction, arrhythmia, respiratory failure, and death.Section 6 ¿patient care and management¿ lists thromboembolism as a potential late postimplant complication, and also provides the recommended anticoagulation regimen, including the international normalized ratio (inr) range, as well as suggested anticoagulation modifications.This section states that right ventricular dysfunction, especially when combined with elevated pulmonary vascular resistance, may limit the effectiveness of the left ventricular assist system due to reduced filling of the pump.It also lists typical treatment options.This section also lists arrhythmia as a potential late postimplant complication.No further information was provided.The manufacturer is closing the file on this event.
|